Kiropraktisk Klinik Ballerup ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 2.5% 4.0% 3.3% 3.9%  
Credit score (0-100)  0 62 48 54 50  
Credit rating  N/A BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 2,518 2,744 2,388 2,467  
EBITDA  0.0 870 883 565 649  
EBIT  0.0 626 634 313 397  
Pre-tax profit (PTP)  0.0 537.6 928.2 312.3 396.6  
Net earnings  0.0 419.4 735.9 243.6 309.3  
Pre-tax profit without non-rec. items  0.0 538 928 312 397  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 236 105 63.6 21.9  
Shareholders equity total  0.0 5,306 1,808 1,576 1,385  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 6,081 2,359 1,994 1,806  

Net Debt  0.0 -3,566 -353 -331 -322  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 2,518 2,744 2,388 2,467  
Gross profit growth  0.0% 0.0% 9.0% -13.0% 3.3%  
Employees  0 0 0 0 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 6,081 2,359 1,994 1,806  
Balance sheet change%  0.0% 0.0% -61.2% -15.4% -9.4%  
Added value  0.0 870.4 883.2 562.1 648.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 1,884 -590 -504 -504  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 24.9% 23.1% 13.1% 16.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 10.6% 22.1% 14.4% 20.9%  
ROI %  0.0% 11.2% 23.5% 15.4% 22.3%  
ROE %  0.0% 7.9% 20.7% 14.4% 20.9%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 87.3% 76.6% 79.0% 76.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -409.7% -40.0% -58.6% -49.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 11.5 3.0 4.4 3.2  
Current Ratio  0.0 11.5 3.0 4.4 3.2  
Cash and cash equivalent  0.0 3,566.5 353.2 331.1 321.7  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 3,575.3 354.6 325.0 334.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 216  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 216  
EBIT / employee  0 0 0 0 132  
Net earnings / employee  0 0 0 0 103